Stanford Med Students Offered Option to Study Their Own Genotype Data
By GenomeWeb,
GenomeWeb Daily News
| 06. 07. 2010
Stanford University School of Medicine today said that it will offer a new course that gives medical and graduate students an option to study their personal genotype data.
The university said that it believes it is the first medical school to offer students such a course. However, the University of Pennsylvania School of Medicine offered its fourth-year medical students a similar course in personalized medicine this past year.
In the Stanford course, students will learn how to analyze, evaluate, and interpret the genetic data, the limitations of existing technologies, and the legal and ethical issues surrounding personal genotyping.
The course will be an elective and will be offered during the school's summer quarter, which begins June 21.
The UPenn course also included a discussion of the ethical, legal, and social implications of personalized medicine, according to Professor Reed Pyeritz, who offered the course and is director of the school's Center for the Integration of Genetic Healthcare Technologies. Students in the UPenn course were offered an option to have their genome scanned by the Coriell Personalized Medicine Collaborative.
Recently, the University...
Related Articles
By Staff, GMWatch | 03.28.2026
Following a recent podcast interview we were asked whether there is any solid scientific research looking at how gene expression or molecular composition in genetically modified (GM) plants differs from conventionally bred plants. As this is an interesting and important...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...
By Rowan Walrath and Laurel Oldach, Chemical & Engineering News | 03.04.2026
Washington, DC—At a press conference held at the US Department of Health and Human Services headquarters on Feb. 23, two doctors from the University of Pennsylvania and Children’s Hospital of Philadelphia spoke about their hope for the future of...
